You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MAZE Sale Disclosure
Bernstein Harold · SEC Form 4 · Filed Aug 14, 2026
Sale
Calculated transaction value
$445.62K
Bernstein Harold President, R&d & CMO
MAZE
Maze Therapeutics
MAZE
Transaction date
Aug 13, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed 1 day later
MAZE daily price context
Close on/before transaction
$27.66
Aug 13, 2026
First close after public filing
$27.95
Aug 17, 2026
30-day return after filing
-11.74%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 16,142 shares @ $27.61
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002050172-26-000028
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$613.82K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Maze Therapeutics, Inc. MAZE | Exercise | Aug 13, 2026 | $168.2K |
| Maze Therapeutics, Inc. MAZE Current | Sale | Aug 13, 2026 | $445.62K |
| Maze Therapeutics, Inc. MAZE | Exercise | Aug 13, 2026 | $0 |